(Q45240499)

11 December 2017

Effects of single and long-term administration of wheat albumin on blood glucose control: randomized controlled clinical trials (English)

1 reference

11 December 2017

1 reference

Kodama T

1

1 reference

11 December 2017

Miyazaki T

2

1 reference

11 December 2017

Kitamura I

3

1 reference

11 December 2017

Suzuki Y

4

1 reference

11 December 2017

Namba Y

5

1 reference

11 December 2017

Sakurai J

6

1 reference

11 December 2017

Torikai Y

7

1 reference

11 December 2017

Inoue S

8

1 reference

11 December 2017

1 March 2005

1 reference

European Journal of Clinical Nutrition

11 December 2017

1 reference

11 December 2017

59

1 reference

11 December 2017

3

1 reference

11 December 2017

384-392

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ejcn.1602085

11 December 2017

0 references

cites work

Identification of the major allergens in wheat flour responsible for baker's asthma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602085

The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602085

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602085

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602085

Character of a wheat amylase inhibitor preparation and effects on fasting human pancreaticobiliary secretions and hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602085

Acarbose in the treatment of elderly patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602085

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602085

Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602085

Complete amino acid sequence of an α-amylase inhibitor in wheat kernel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602085

Tertiary and quaternary structures of 0.19 alpha-amylase inhibitor from wheat kernel determined by X-ray analysis at 2.06 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602085

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602085

Nateglinide improves early insulin secretion and controls postprandial glucose excursions in a prediabetic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602085

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602085

Acarbose-induced acute severe hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602085

7 January 2021

Acarbose-induced acute hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602085

7 January 2021

Acarbose-induced hepatic injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602085

7 January 2021

Hepatic necrosis with cholestasis induced by long-term voglibose administration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602085

7 January 2021

Effect of a wheat amylase inhibitor on canine carbohydrate digestion, gastrointestinal function, and pancreatic growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602085

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602085

7 January 2021

Identifiers

DOI

10.1038/SJ.EJCN.1602085

1 reference

Dimensions Publication ID

11 December 2017

0 references

1 reference